Literature DB >> 23809712

Clostridium difficile Infection.

Christopher L Knight1, Christina M Surawicz.   

Abstract

Clostridium difficile is emerging as a common cause of infectious diarrhea. Incidence has increased dramatically since 2000, associated with a new strain that features both increased toxin production and increased resistance to antibiotics. For patients with mild to moderate disease, oral metronidazole is usually the first choice of treatment, and those with severe disease should be treated with vancomycin, with additional intravenous metronidazole in some cases. Fecal microbiota transplantation is a potentially promising therapy for patients with multiple recurrences of C difficile infection. Prevention of nosocomial transmission is crucial to reducing disease outbreaks in health care settings.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23809712     DOI: 10.1016/j.mcna.2013.02.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  7 in total

1.  The microbiome: what it means for medicine.

Authors:  Emma Allen-Vercoe; Elaine O Petrof
Journal:  Br J Gen Pract       Date:  2014-03       Impact factor: 5.386

2.  Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.

Authors:  Peter C Konturek; Drilon Haziri; Harry Helfritzsch; Thomas Hess; Igor A Harsch
Journal:  Med Princ Pract       Date:  2016-12-15       Impact factor: 1.927

3.  THAs Performed Within 6 Months of Clostridioides difficile Infection Are Associated with Increased Risk of 90-Day Complications.

Authors:  Scott J Douglas; Ethan A Remily; Oliver C Sax; Sahir S Pervaiz; Evan B Polsky; Ronald E Delanois
Journal:  Clin Orthop Relat Res       Date:  2021-12-01       Impact factor: 4.176

4.  A Risk Score to Predict Clostridioides difficile Infection.

Authors:  Laurie Aukes; Bruce Fireman; Edwin Lewis; Julius Timbol; John Hansen; Holly Yu; Bing Cai; Elisa Gonzalez; Jody Lawrence; Nicola P Klein
Journal:  Open Forum Infect Dis       Date:  2021-02-04       Impact factor: 3.835

Review 5.  Appendicectomy and clostridium difficile infection: is there a link?

Authors:  Charalampos Seretis; Fotios Seretis; Kolitha Goonetilleke
Journal:  J Clin Med Res       Date:  2014-05-22

Review 6.  Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options.

Authors:  Mehdi Goudarzi; Sima Sadat Seyedjavadi; Hossein Goudarzi; Elnaz Mehdizadeh Aghdam; Saeed Nazeri
Journal:  Scientifica (Cairo)       Date:  2014-06-01

7.  The Burden of Clostridium difficile after Cervical Spine Surgery.

Authors:  Javier Z Guzman; Branko Skovrlj; Edward S Rothenberg; Young Lu; Steven McAnany; Samuel K Cho; Andrew C Hecht; Sheeraz A Qureshi
Journal:  Global Spine J       Date:  2015-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.